Biocryst Pharmaceuticals (BCRX) Tax Rate (2021 - 2026)
Biocryst Pharmaceuticals' (BCRX) quarterly Tax Rate came in at 1.36% in Q2 2026, down 2024.0% on a YoY basis from 0.07% in Q2 2025, and up 1074.73% quarter-over-quarter from 0.14% in Q1 2026.
Powered by 
Analysis
Biocryst Pharmaceuticals (BCRX) Tax Rate (2021 - 2026) Analysis & Trends
Biocryst Pharmaceuticals (BCRX) has reported Tax Rate for 6 consecutive years, with 1.36% the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Tax Rate fell 2024.0% year-over-year to 1.36%; the trailing twelve-month figure through Jun 2026 stood at 0.91% (up 1001.0% YoY), and the FY2025 full-year result was 1.32%, up 354.0% from the prior year.
- Tax Rate improved to 1.36% in Q2 2026 per BCRX's latest filing, from 0.14% in the prior quarter.
- Across five years, Tax Rate topped out at 95.78% in Q1 2025 and bottomed at 6.34% in Q3 2025.
- Historically, Tax Rate has averaged 5.37% across 5 years, with a median of 0.96% in 2023.
- The sharpest annual moves came in 2025 and 2026: Tax Rate soared 9682 bps in 2025, then slumped 9592 bps in 2026.
- Over 5 years, Tax Rate stood at 0.11% in 2022, then jumped by 2230 bps to 2.27% in 2023, then sank by 237 bps to 3.09% in 2024, then soared by 128 bps to 0.88% in 2025, then surged by 55 bps to 1.36% in 2026.
- According to Business Quant data, Tax Rate over the past three periods registered 1.36%, 0.14%, and 0.88% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 210.98 Bn | 196.99 Bn | 7.24 Bn | 14.20% |
| 2 | Gilead Sciences | 181.24 Bn | 178.06 Bn | 6.22 Bn | -2.36% |
| 3 | Vertex Pharmaceuticals | 132.38 Bn | 124.53 Bn | 2.84 Bn | 20.98% |
| 4 | Regeneron Pharmaceuticals | 82.97 Bn | 74.97 Bn | 3.93 Bn | 15.11% |
| 5 | Argenx Se | 61.59 Bn | 56.41 Bn | 1.37 Bn | -10.89% |
| 6 | Moderna | 54.80 Bn | 49.67 Bn | 52.00 Mn | -1.96% |
| 7 | Alnylam Pharmaceuticals | 34.09 Bn | 30.78 Bn | 992.69 Mn | 7.49% |
| 8 | Biogen | 31.34 Bn | 30.05 Bn | 1.96 Bn | 26.36% |
| 9 | Roivant Sciences | 30.11 Bn | 30.11 Bn | 1.16 Mn | 1.34% |
| 10 | Biocryst Pharmaceuticals | 2.32 Bn | 1.96 Bn | 214.41 Mn | 1.36% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.36% |
| Mar 31, 2026 | -0.14% |
| Dec 31, 2025 | 0.88% |
| Sep 30, 2025 | -6.34% |
| Jun 30, 2025 | 21.60% |
| Mar 31, 2025 | 95.78% |
| Dec 31, 2024 | -3.09% |
| Sep 30, 2024 | -4.36% |
| Jun 30, 2024 | -1.38% |
| Mar 31, 2024 | -1.04% |
| Dec 31, 2023 | 2.27% |
| Sep 30, 2023 | -0.92% |
| Jun 30, 2023 | -0.99% |
| Mar 31, 2023 | -1.27% |
| Dec 31, 2022 | -0.11% |
| Sep 30, 2022 | -3.71% |
| Jun 30, 2022 | -1.48% |
| Mar 31, 2022 | -0.38% |
| Dec 31, 2021 | -14.51% |